TTNP
Titan Pharmaceuticals Inc
$
3.930
- Overview
- Forecast
- Valuation
- Earnings
Line
|
Candle
1D
5D
1M
3M
6M
YTD
1Y
5Y
High
3.930
Open
3.8019
VWAP
3.90
Vol
5.29K
Mkt Cap
5.23M
Low
3.8019
Amount
20.63K
EV/EBITDA(TTM)
--
Total Shares
914.23K
EV
3.27M
EV/OCF(TTM)
--
P/S(TTM)
--
Titan Pharmaceuticals, Inc. is a pharmaceutical company. Its product pipeline includes Kappa Opioid Receptor Agonist (TP-2021) Implant, which is used for the treatment of moderate-to-severe chronic pruritus, and Nalmefene Implant, which is for the prevention of relapse in OUD patients following detoxification from opioids Its product development programs are in non-clinical stages of development.
Show More
Valuation Metrics
The current forward P/E ratio for Titan Pharmaceuticals Inc (TTNP.O) is -0.46, compared to its 5-year average forward P/E of -2.36. For a more detailed relative valuation and DCF analysis to assess Titan Pharmaceuticals Inc 's fair value, click here.
Forward PE
The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
N/A
5Y Average PE
-2.36
Current PE
-0.46
Overvalued PE
3.71
Undervalued PE
-8.43
Forward EV/EBITDA
The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
N/A
5Y Average EV/EBITDA
0.03
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
0.14
Undervalued EV/EBITDA
-0.08
Forward PS
The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
N/A
5Y Average PS
54.85
Current PS
0.67
Overvalued PS
140.92
Undervalued PS
-31.22
Financials
Annual
Quarterly
FY2025Q1
N/A
Total Revenue
FY2025Q1
YoY :
-49.76%
-534.00K
Operating Profit
FY2025Q1
YoY :
-46.89%
-563.00K
Net Income after Tax
FY2025Q1
YoY :
-50.00%
-0.62
EPS - Diluted
FY2025Q1
N/A
Free Cash Flow
FY2025Q1
N/A
Gross Profit Margin - %
FY2025Q1
N/A
FCF Margin - %
FY2025Q1
N/A
Net Margin - %
Trading Trends
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
0-3
Months
0.0
Volume
0
3-6
Months
0.0
Volume
0
6-9
Months
0.0
Volume
0
0-12
Months
0.0
Volume
0
Bought
0-3
0
0.0
Volume
Months
3-6
0
0.0
Volume
Months
6-9
0
0.0
Volume
Months
0-12
0
0.0
Volume
Months
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
TTNP News & Events
Events Timeline
2025-06-03 (ET)
2025-06-03
08:48:58
Titan announces filing of registration statement for proposed combination
2024-11-27 (ET)
2024-11-27
15:07:30
Titan Pharmaceuticals receives Nasdaq notice of non-compliance
Sign Up For More Events
Sign Up For More Events
News
7.0
08-06GlobenewswireSHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SCS, HLVX, BSGM, TTNP on Behalf of Shareholders
7.0
07-30GlobenewswireSHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ITOS, VBTX, TTNP on Behalf of Shareholders July 31, 2025
7.0
07-29PRnewswireSHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates BASE, SPTN, TTNP on Behalf of Shareholders
Sign Up For More News
People Also Watch
FAQ
What is Titan Pharmaceuticals Inc (TTNP) stock price today?
The current price of TTNP is 3.93 USD — it has increased 0.26 % in the last trading day.
What is Titan Pharmaceuticals Inc (TTNP)'s business?
What is the price predicton of TTNP Stock?
What is Titan Pharmaceuticals Inc (TTNP)'s revenue for the last quarter?
What is Titan Pharmaceuticals Inc (TTNP)'s earnings per share (EPS) for the last quarter?
What changes have occurred in the market's expectations for Titan Pharmaceuticals Inc (TTNP)'s fundamentals?
How many employees does Titan Pharmaceuticals Inc (TTNP). have?